 |
Email the Society |
 |
Donations |
ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001
Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')
Office Hours:
Wednesdays, 10am-3pm
Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237
SA country callers:
Ph: 1300 128 339
(local call)
FIBROMYALGIA HELP: Contact Fibromyalgia SA at the Arthritis Foundation of SA 118 Richmond Road, Marleston 5033 Ph: (08) 8379 5711 |
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
|
Disclaimer
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | |||
|
Fibromyalgia study involves medication and conversation
Friday 12 March 2010
Fibromyalgia Study Involves Medication and Conversation
INDIANAPOLIS — The Indiana University Fibromyalgia Clinical Research Center is evaluating communication as a therapeutic tool in treating the often painful yet common disease.
This is the third in a continuing series of research studies for fibromyalgia entitled Drug and Talk Therapy for Fibromyalgia.
The IU center is conducting this study to better understand how talk therapies, such as education and cognitive behavioral therapy, can improve the therapeutic benefits of medications for fibromyalgia.
Savella®, also known as milnacipran, is an FDA approved drug for fibromyalgia. The safety and efficacy of Savella has been established in two nationwide clinical studies involving more than 2,000 patients with fibromyalgia. Since Savella has already been shown to be effective when used in isolation to treat fibromyalgia, IU researchers are conducting the study to determine whether combination treatment (Savella + talk therapy) is more effective than Savella alone or talk therapy alone.
Participants are randomly assigned to receive either Savella or a placebo (sugar pill) and will receive either cognitive behavior therapy or an educational phone series.
Those interested in learning more about this study should contact the Fibromyalgia Clinical Research Center at 317-278-3971.
The study is funded by National Institutes of Health.
# # #
Media Contact:
Mary Hardin
(317) 274-7722
(317) 695-4090 (cell)
mhardin@iupui.edu
The article originally appeared here.
|
More Fibromyalgia News |
blog comments powered by Disqus
Previous Page |
